Siblings Books/Book Section [5/6] Periodical Articles [82/82] Collection Statistics Item counts issued in 3 years:2(11.76%) Items With Fulltext:14(82.35%) Download counts of the item Download times greater than 0:14(100.00%) Download times greater than 100:13(92.86%) Total Bitstream Download Counts:6926(15.13%) Last Update: 2024-12-01 10:58 Top Upload Loading... Top Download Loading... Recent Submissions Atezolizumab plus bevacizumab for p... A prospective phase II study of biw... TCOG T1308 study: The final results... Assessing benefit and consistency o... Prediction of hepatitis B virus rea... Prevention of chemotherapy-induced ... Long-term outcome of chemotherapy-i... KRAS mutation status-stratified ran... Impact of ROS1, ALK, and/or MET exp... EGFR variant III act as the major d...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 11-17 of 17. (2 Page(s) Totally) << < 1 2  View [10|25|50] records per page

Date	Title	Relation
2013-04	EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390.
2012-03	CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage	Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	European Journal of Cancer. 2011 Sep 23;47:S547-S548.
2011-05	Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
2011-05	The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction	Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
2011-05	Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
2011-05	Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients	Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.

Showing items 11-17 of 17. (2 Page(s) Totally) << < 1 2  View [10|25|50] records per page